[
  {
    "ts": null,
    "headline": "Canada Point of Care Molecular Diagnostics Market Research Report 2025-2030: Digital Health Platforms, Multiplex PCR Adoption, and Pharmacogenomics Programs Bolster Growth",
    "summary": "The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 million by 2030, with a CAGR of 8.15%. Key drivers include an aging population increasing demand for faster diagnostics and infectious disease preparedness emphasized by recent outbreaks. Ontario leads the market due to its robust healthcare infrastructure. Key trends involve digital health integration and personalized medicine advancements, with major market players including",
    "url": "https://finnhub.io/api/news?id=a094440b04da71f6dc9987b3360e15539995019792f84899ba479005cad39a05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771238760,
      "headline": "Canada Point of Care Molecular Diagnostics Market Research Report 2025-2030: Digital Health Platforms, Multiplex PCR Adoption, and Pharmacogenomics Programs Bolster Growth",
      "id": 139113424,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 million by 2030, with a CAGR of 8.15%. Key drivers include an aging population increasing demand for faster diagnostics and infectious disease preparedness emphasized by recent outbreaks. Ontario leads the market due to its robust healthcare infrastructure. Key trends involve digital health integration and personalized medicine advancements, with major market players including",
      "url": "https://finnhub.io/api/news?id=a094440b04da71f6dc9987b3360e15539995019792f84899ba479005cad39a05"
    }
  },
  {
    "ts": null,
    "headline": "2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down",
    "summary": "Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.",
    "url": "https://finnhub.io/api/news?id=24f3a7c03eb9b53d9af91099b3aee3dad21d4d7b37e802f3f0426a72eb41f4c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771216862,
      "headline": "2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down",
      "id": 139116087,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.",
      "url": "https://finnhub.io/api/news?id=24f3a7c03eb9b53d9af91099b3aee3dad21d4d7b37e802f3f0426a72eb41f4c7"
    }
  }
]